Medical Tubing and Extrusion

Medical tubing and extrusion technologies

Adagio Medical

Adagio treats first patient with next-gen low-temp ablation system

By

Adagio Medical (Nasdaq:ADGM) today announced the successful treatment of the first patient with its next-generation vCLAS technology. The treatment took place under the FDA's Expanded Access authorization. It utilized the company's Ultra Ultra-Low Temperature Ablation (ULTA) system. Laguna Hills, California-based Adagio said the patient … [Read more...] about Adagio treats first patient with next-gen low-temp ablation system

Adagio submits ventricular ablation system to FDA

By

Adagio Medical (Nasdaq:ADGM) announced today that it submitted its premarket approval (PMA) application to the FDA for its vCLAS system. The company submitted its vCLAS ventricular ablation system for the treatment of drug-refractory, recurrent, sustained monomorphic ventricular tachycardia (VT) in patients with ischemic or non-ischemic … [Read more...] about Adagio submits ventricular ablation system to FDA

Adagio ventricular ablation tech performs well in clinical trial

By

Adagio Medical (Nasdaq:ADGM) today announced new six-month results from its FULCRUM-VT clinical trial evaluating its ablation technology. FULCRUM-VT evaluates the company’s vCLAS cryoablation technology for treating cardiovascular disease. Laguna Hills, California-based Adagio built its vCLAS cryoablation catheter on its proprietary ultra-low … [Read more...] about Adagio ventricular ablation tech performs well in clinical trial

Adagio Medical wins FDA IDE to expand ventricular ablation study to use next-gen catheter

By

Adagio Medical (Nasdaq:ADGM) announced today that it received FDA investigational device exemption (IDE) to expand its FULCRUM-VT trial. FULCRUM-VT evaluates the company's vCLAS cryoablation technology for treating cardiovascular disease. Laguna Hills, California-based Adagio built its vCLAS cryoablation catheter on its proprietary ultra-low … [Read more...] about Adagio Medical wins FDA IDE to expand ventricular ablation study to use next-gen catheter

Adagio Medical appoints longtime Medtronic exec Sean Salmon to board

By

Adagio Medical (Nasdaq:ADGM) announced that it appointed Sean Salmon to its board of directors. With his appointment, Salmon will also serve on the audit committee and compensation committee for the Laguna Hills, California-based company, which develops cryoablation technology for treating cardiovascular diseases. Adagio built its vCLAS … [Read more...] about Adagio Medical appoints longtime Medtronic exec Sean Salmon to board

Adagio completes enrollment in ultra-low temp cryoablation trial

By

Adagio Medical (Nasdaq:ADGM) announced today that it completed enrollment for its FULCRUM-VT pivotal FDA IDE study. FULCRUM-VT evaluates the company's vCLAS cryoablation system for the ablation of monomorphic ventricular tachycardia (MMVT). The Laguna Hills, California–based company built its vCLAS cryoablation catheter on its proprietary … [Read more...] about Adagio completes enrollment in ultra-low temp cryoablation trial

Adagio Medical wins FDA breakthrough nod for cryoablation tech

By

Adagio Medical (Nasdaq:ADGM) announced today that it received FDA breakthrough device designation for its vCLAS cryoablation system. The Laguna Hills, California-based company based its vCLAS cryoablation catheter on its proprietary ultra-low cryoablation technology (ULCT). It aims to address the challenges of ventricular tachycardia (VT) … [Read more...] about Adagio Medical wins FDA breakthrough nod for cryoablation tech

Adagio Medical to restructure, reduce workforce

By

Adagio Medical (Nasdaq:ADGM) announced today that it plans a corporate restructuring and realignment of resources. The Laguna Hills, California–based company, which develops catheter ablation technologies for treating cardiac arrhythmias, wants to prioritize its FULCRUM-VT pivotal FDA investigational device exemption (IDE) clinical trial … [Read more...] about Adagio Medical to restructure, reduce workforce

Adagio Medical picks medtech veteran Todd Usen as new CEO

By

Adagio Medical (Nasdaq:ADGM) announced today that it appointed Todd Usen as its new CEO and board director. Usen's appointment follows the departure of Olav Bergheim, the company's founder, CEO and board chair, effective Dec. 13. The company concurrently made Usen CEO and Orly Mishan chair of the board of directors. Bergheim intends to continue … [Read more...] about Adagio Medical picks medtech veteran Todd Usen as new CEO

Ablation tech developer Adagio Medical to go public in SPAC deal

By

Arya Sciences Acquisition Corp IV agreed to a business combination with Adagio Medical, taking the cardiac ablation company public. Upon the closing of the transaction, Adagio is set to become a subsidiary of Aja Holdco, still operating under its existing management team and under the name "Adagio Medical." Arya expects to list the combined … [Read more...] about Ablation tech developer Adagio Medical to go public in SPAC deal